The Canadian Conference on Ovarian Cancer Research (CCOCR), happening May 29 – June 1 in Vancouver, brings together leading experts to share knowledge and showcase research excellence.
Attendees will hear from an outstanding lineup of speakers, including:
- Dr. James Brenton’s (Cambridge, UK) research focuses on advancing understanding of the genomic complexity of ovarian cancer and identifying blood and tissue biomarkers to predict therapy
- Dr. Mercedes Castiel (New York City, NY) has particular expertise in cancer survivorship, with a history of developing and directing numerous women’s cancer survivorship programs across the United States
- Dr. Ronny Drapkin’s (Philadelphia, PA) research focuses on the evolution of ovarian cancers and played a pivotal role in the identification of the fallopian tube as the origin of most high-grade serous ovarian cancers
- Dr. William Foulkes (Montreal, QC)has made numerous discoveries in cancer genetics, including defining how to treat BRCA1-related cancers clinically and characterizing several founder mutations
- Dr. Yvette Drew (Vancouver, BC) specializes in the care and management of patients with gynecological cancers and the development and delivery of early phase clinical trials
- Dr. Jessica McAlpine’s (Vancouver, BC) research focuses on the development and application of molecular tools to stratify risk and direct care for endometrial and ovarian cancers
CCOCR 2026 is an opportunity to exchange ideas, strengthen partnerships, and help shape the future of ovarian cancer research in Canada and beyond.
Learn more and register at ccocr.ca.
Stay in the loop with the Gynecologic Cancer Initiative: